Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome - Wikidata - wikimedia - TriplyDB

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

http://www.wikidata.org/entity/Q34108411

about

Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome The current status of targeting BAFF/BLyS for autoimmune diseases SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease Recent advances in primary Sjogren's syndrome Rituximab Effectiveness and Safety for Treating Primary Sjögren's Syndrome (pSS): Systematic Review and Meta-Analysis B-cell survival factors in autoimmune rheumatic disorders Cellular targeting in autoimmunity The clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to man Factors regulating immunoglobulin production by normal and disease-associated plasma cells Piecing together the humoral and cellular mechanisms of immune thrombocytopenia Multiple Roles for B-Lymphocytes in Sjogren's Syndrome Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis Intestinal B cell-activating factor: an indicator of non-IgE-mediated hypersensitivity reactions to food?BAFF and rheumatic autoimmune disorders: implications for disease management and therapy A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review APRIL-deficient mice have normal immune system development Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity.Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion Construction and characterization of an enhanced GFP-tagged anti-BAFF scFv antibody.BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients.Novel treatments for immune thrombocytopenia.Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.Sjogren's syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions.Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation.Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency.BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.BLyS and APRIL in rheumatoid arthritis.Gene cloning, expression and functional characterization of a proliferation-inducing ligand (APRIL) from hedgehog (Erinaceus europaeus).Similarities and differences between selective and nonselective BAFF blockade in murine SLE

P2860

Q21195408-4ACFCEE9-7DF9-4107-83C6-B1EEBC62B636 Q24794011-FDF7E945-6A8E-44E8-99E4-E6EA863DCE59 Q24796930-1D8642FD-CC36-4F81-AD76-EAB1DA177C08 Q24804613-F09EAA5F-D5D7-484F-B3A3-16998D58E8CC Q24805316-B56689CC-7F8F-4049-A792-4008AC2E9469 Q26745015-C19049D0-A15F-41DC-9EF6-A277F7AF2DA3 Q26747049-F0014D9B-8831-448B-97ED-80FA85833EFB Q26753072-4BC7F0FE-89F6-4FA0-BC53-49F199846A29 Q26796484-20BF9E78-DEFD-41FD-995D-AE4C2CD29AF8 Q26824580-5D1E7CD4-6873-41AA-A0DC-F4E5B113ECAD Q26825196-AFBE82A5-998C-4A45-A92D-5C83E7A2BB43 Q27021855-DE112F26-51B8-4E0D-9F01-4DCCBCE8FDA7 Q27024841-180D7FA1-937D-4CB3-9E4D-557CF6C23E1D Q28068695-5D35C6A9-5E99-4E4B-A5AF-A17D6DDDE66C Q28251763-2DAC9436-9DB0-44F8-A51A-9EA2E683AA8D Q28278210-739410F4-C64F-492C-AF59-C0C10CD02C7D Q28292058-3FD815D9-E7F2-4279-85D5-7758583674F8 Q28293722-74400401-F1E2-45AB-A285-76CC807BB752 Q28299847-010BD9C8-683A-4492-97ED-206F806B19F8 Q28511017-DEC32B3D-9D37-496B-8281-DE196FCDEE28 Q30415556-13B0F505-392B-4233-8719-773ED7285113 Q30566367-5A80CEB9-97E8-4F15-B84F-563C0C07CDF3 Q33329813-30F3FECC-777E-4B19-A1B3-9EE4DA7A1584 Q33381985-9C5131BC-664F-46BA-843E-B939648A5CBC Q33385389-06198613-A8D8-46C7-AE67-EDC1ED44A864 Q33390753-9D79BF5F-6C3F-4EA5-80C4-C03DAE9CCC41 Q33414132-EEB3970E-FA84-469E-A71D-F0F13253F1D4 Q33429051-82F345A6-BF7A-4860-868B-3ADA7387C171 Q33619691-FAD83FBF-3208-4F0D-B03F-A9D8EB58D57F Q33752808-95038BC2-7C3A-47F1-B99B-7562D6BCFE8A Q33819490-209F4F83-D902-4098-BEF5-3F8F11E6FBEE Q33979830-04D6493D-D4F5-4CB1-A3D5-590BBC4B49C7 Q33979850-FC3E401C-6700-4B78-A5C9-B65AFCAB4E64 Q34012753-4219EC2E-E752-4EFA-A0EB-6AC7DB1C9BEB Q34013562-D9CC9DA8-B455-4166-8234-AB73FBDF6C78 Q34034515-A47ADD27-CCF5-42E5-81C9-D78C65C54166 Q34047753-C8990404-9B80-4401-8309-5F8837171C6A Q34084521-9FB9C295-C56C-4F02-BD2D-D0B8019EFF26 Q34128107-7854E755-DC78-41C5-8BBF-A2A11BA4E7A8 Q34350295-C2F48F6A-B897-4E77-80BA-303DB091C924

P2860

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

http://www.wikidata.org/entity/Q34108411

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@ast

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@en

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@nl

type

label

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@ast

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@en

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@nl

prefLabel

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@ast

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@en

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@nl

P1433

Q34108411-0A1DD07A-8124-42F0-899A-44361129D2F6

P1476

Q34108411-8FA7D288-18C0-4763-ACAD-9E8D32C46679

P2093

Q34108411-080AB324-4AD7-4BC8-90D1-BB48ACE297D9

Q34108411-0D75FA2E-833C-4E83-8C5E-58B8EF44D668

Q34108411-174BF57C-9875-454B-9D2D-A0F478B30414

Q34108411-2355A484-5644-43A7-A6E6-DE89C3EC1E7F

Q34108411-42F42A22-EB3D-4472-BCE6-1D8DF2F77DAF

Q34108411-4F0227B5-5F18-4A37-A27B-31EB8A39CD4C

Q34108411-5962CEBB-7E8C-4C25-97D0-2CC46D9E17C4

Q34108411-5AD21B4F-15DF-4D45-80B6-5D6196EBBD66

Q34108411-74437427-1E3F-4577-821B-4FEB0140B6C9

Q34108411-A7225238-AF74-4BC5-9A96-E032DE2C8F0D

P2860

Q34108411-0C1BD731-5E1D-43F7-8722-5F57F0E7E9BD

Q34108411-13D0BEDF-CB9E-4BB6-BEC1-F88C9569E82C

Q34108411-14CE832E-0EEF-4C3E-B25C-76A9BAA08411

Q34108411-1B1D2707-2E5C-471E-B8D5-2D5862F8EAC2

Q34108411-22D4BD3E-1BA9-4B7E-AAE6-24FA5F75E54C

Q34108411-2C8425B7-2D11-4885-9986-F11B28E7F857

Q34108411-34B04BFF-A13B-4213-9F43-ECF5B8C600EC

Q34108411-357D2404-8892-4E21-A899-76F0621EB4E2

Q34108411-368F7159-3801-4D8B-8AA4-6C5B7AE037BB

Q34108411-36F8B803-FA34-4C8E-91CA-5D44DDA9C924

P304

Q34108411-C026C328-488B-4965-9EA9-C76C0AF06175

P31

Q34108411-2C895EA7-C411-45BB-9200-B6EF42D5F638

P356

Q34108411-8249B437-919D-4E03-8000-A36FC5B2271D

P407

Q34108411-95C35B7F-95B7-483B-BDDE-5E3638F53160

P433

Q34108411-D8B1850C-ED25-49CF-84FA-03F95D62168F

P478

Q34108411-D5EEF890-EB2E-41F6-8D93-ABA92BB878C7

P50

Q34108411-EAF9D522-58B8-4D86-9F90-9065B8272565

P577

Q34108411-920CA142-8DE3-4EF7-8BA9-4E1BD7467982

P698

Q34108411-16780D66-14ED-4126-AA05-7FD20B2F08A4

P921

Q34108411-7363D0D8-07ED-4568-AAF8-A4F58B691FB8

P932

Q34108411-944248EB-E23F-43C8-9199-4E935BF866D0

P356

P1433

Journal of Clinical Investigation

P1476

Association of BAFF/BLyS overe ...... iation with Sjögren's syndrome

@en

P2093

Anne H Cutler

http://www.w3.org/2001/XMLSchema#string

Carl Olson

http://www.w3.org/2001/XMLSchema#string

Charles R Mackay

http://www.w3.org/2001/XMLSchema#string

Dana Cavill

http://www.w3.org/2001/XMLSchema#string

Davide Mauri

http://www.w3.org/2001/XMLSchema#string

Fabienne Mackay

http://www.w3.org/2001/XMLSchema#string

Joanna Groom

http://www.w3.org/2001/XMLSchema#string

Julie Wheway

http://www.w3.org/2001/XMLSchema#string

Marcel Batten

http://www.w3.org/2001/XMLSchema#string

Pascal Schneider

http://www.w3.org/2001/XMLSchema#string

P2860

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation

B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1

Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS

NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity

Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity

APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity

P304

59-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI0214121

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11781351

http://www.w3.org/2001/XMLSchema#string

P921

P932

150825

http://www.w3.org/2001/XMLSchema#string